Diphenhydramine Export Market Intelligence: India's 178 Suppliers Shipping to 82 Countries — TransData Nexus 2026

Q: Who are the top diphenhydramine exporters from India?

The top diphenhydramine exporters from India are: 1. ELYSIUM PHARMACEUTICALS LTD — $6.1M (19.0% market share); 2. MICRO LABS LIMITED — $5.5M (17.2% market share); 3. REAL DRUGS PRIVATE LIMITED — $2.9M (9.0% market share); 4. GRANULES INDIA LIMITED — $2.5M (7.8% market share); 5. TRUECARE BIOMEDIX — $2.2M (6.9% market share). Together they account for 59.9% of India's total diphenhydramine export value.

Q: What is the total export value of diphenhydramine from India?

The total export value of diphenhydramine from India is $32.0M USD, recorded across 1,430 shipment transactions from 178 active exporters to 82 destination countries. The average shipment value is $22.3K.

Q: Which countries import diphenhydramine from India?

India exports diphenhydramine to 82 countries worldwide. The top importing countries are: UNITED STATES (63.9% share, $20.4M), GHANA (16.6% share, $5.3M), ETHIOPIA (2.7% share, $869.9K), CHAD (2.2% share, $708.8K), BENIN (2.1% share, $666.8K). These five markets account for 87.5% of total export value.

Q: What is the average price of diphenhydramine exports from India?

The average unit price for diphenhydramine exports from India is $21.80 USD per unit, with prices ranging from $0.00 to $686.92 depending on formulation, packaging, and order volume. The total market is valued at $32.0M across 1,430 shipments.

Q: Which ports handle diphenhydramine exports from India?

The primary ports for diphenhydramine exports from India are NHAVA SHEVA SEA (INNSA1) (12.2% of shipments), MUNDRA SEA (INMUN1) (9.1% of shipments), MUNDRA SEA (8.7% of shipments), JNPT (5.9% of shipments), JNPT/ NHAVA SHEVA SEA (5.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of diphenhydramine?

India is one of the world's leading exporters of diphenhydramine due to its large base of 178 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports diphenhydramine to 82 countries, demonstrating 42% global market coverage.

Q: What certifications do Indian diphenhydramine exporters need?

Indian diphenhydramine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import diphenhydramine from India?

There are 289 registered buyers importing diphenhydramine from India, spread across 82 countries. The repeat buyer rate is 52.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top diphenhydramine supplier from India?

ELYSIUM PHARMACEUTICALS LTD is the leading diphenhydramine exporter from India with a market share of 19.0% and total export value of $6.1M across 136 shipments. The top 5 suppliers together control 59.9% of total export value.

Suresh Sormare

Diphenhydramine

India Pharmaceutical Trade Intelligence

$32.0M178 Suppliers82 CountriesHS 30049099

ExportsIndia → UNITED STATES63.9%India → GHANA16.6%

ImportsCANADA → India$237.3K IRELAND → India$66.9K

#1 Buyer: CARDINAL 3PL

Diphenhydramine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Diphenhydramine to the World

Between 2022 and 2026, India exported $32.0M worth of diphenhydramine across 1,430 verified shipments to 82 countries — covering 42% of world markets in the Antihistamines & Allergy segment. The largest destination is UNITED STATES (63.9%). ELYSIUM PHARMACEUTICALS LTD leads with a 19.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Diphenhydramine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Diphenhydramine export data snapshot — $32.0M · 178 exporters · 82 countriesTransData Nexus · Indian Customs Data

Top Diphenhydramine Exporters from India

178 active exporters · Ranked by export value

View all 178 →

Top Diphenhydramine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ELYSIUM PHARMACEUTICALS LTD	$6.1M	136	1	19.0%
2	MICRO LABS LIMITED

Top Countries Importing Diphenhydramine from India

82 destination markets · Ranked by import value

All 82 countries →

Top Countries Importing Diphenhydramine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$20.4M	63.9%
2	GHANA	$5.3M	16.6%
3	ETHIOPIA	$869.9K	2.7%
4	CHAD	$708.8K	2.2%
5	BENIN	$666.8K	2.1%
6	SUDAN	$594.7K	1.9%
7	NIGERIA	$436.5K	1.4%
8	COSTA RICA	$263.1K	0.8%
9	SOUTH AFRICA	$249.5K	0.8%
10	UNITED ARAB EMIRATES	$239.3K	0.7%

UNITED STATES is India's largest diphenhydramine export destination, absorbing 63.9% of total exports worth $20.4M. The top 5 importing countries — UNITED STATES, GHANA, ETHIOPIA, CHAD, BENIN — together account for 87.5% of India's total diphenhydramine export value. The remaining 77 destination countries collectively receive the other 12.5%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Diphenhydramine to India?

7 origin countries · Total import value: $336.2K

India imports diphenhydramine from 7 countries with a combined import value of $336.2K. The largest supplier is CANADA ($237.3K, 2 shipments), followed by IRELAND and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Diphenhydramine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$237.3K	2	70.6%
2	IRELAND	$66.9K	2	19.9%
3	GERMANY	$20.4K	3	6.1%
4	UNITED STATES	$9.6K	27	2.9%
5	UNITED KINGDOM	$1.4K	2	0.4%
6	JAPAN	$645	6	0.2%
7	MALTA	$0	2	0.0%

CANADA is the largest supplier of diphenhydramine to India, accounting for 70.6% of total import value. The top 5 origin countries — CANADA, IRELAND, GERMANY, UNITED STATES, UNITED KINGDOM — together supply 99.8% of India's diphenhydramine imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Diphenhydramine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Diphenhydramine, a first-generation antihistamine, is widely utilized in the United States for its sedative and anti-allergic properties. The U.S. Food and Drug Administration (FDA) has approved numerous Abbreviated New Drug Applications (ANDAs) for diphenhydramine products, indicating a well-established generic market. While specific approval dates for recent ANDAs are not detailed in the available sources, the FDA's Orange Book provides comprehensive listings of approved drug products, including diphenhydramine formulations.

Importantly, as of March 2026, there are no active FDA import alerts specifically targeting diphenhydramine products from India. This absence suggests that Indian manufacturers exporting diphenhydramine to the U.S. are generally in compliance with FDA regulations. However, it's crucial for exporters to remain vigilant, as the FDA can impose import alerts if products are found to violate regulatory standards. For instance, the FDA issues import alerts to protect consumers against products with a history of known violations, allowing for detention without physical examination (DWPE) of such products.

Given that 63.9% of India's diphenhydramine exports are destined for the United States, it is imperative for Indian exporters to adhere strictly to FDA requirements. This includes ensuring compliance with Good Manufacturing Practices (GMP), accurate labeling, and prompt reporting of any adverse events. Maintaining compliance not only facilitates uninterrupted market access but also upholds the reputation of Indian pharmaceutical products in the U.S. market.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), diphenhydramine is regulated as an over-the-counter (OTC) medicine for the treatment of allergies and insomnia. Marketing authorizations are granted by national regulatory agencies or, for centralized procedures, by the European Medicines Agency (EMA). Manufacturers must comply with the EU's Good Manufacturing Practice (GMP) guidelines, which ensure that products are consistently produced and controlled according to quality standards. These guidelines are detailed in EudraLex Volume 4.

Notably, in January 2010, Wyeth Consumer Healthcare withdrew its application for a marketing authorization for a combination product containing ibuprofen and diphenhydramine hydrochloride. The withdrawal was based on the Committee for Medicinal Products for Human Use's (CHMP) view that the data provided did not allow for a positive benefit-risk assessment (ema.europa.eu). This underscores the importance of robust clinical data and compliance with regulatory standards for successful market entry in the EU and UK.

3WHO Essential Medicines & Global Standards

Diphenhydramine is included in the World Health Organization's (WHO) Model List of Essential Medicines, recognizing its importance in a basic health system. The specific edition of the list should be consulted for the most current information. Inclusion in this list signifies the drug's critical role in addressing public health needs.

Regarding pharmacopoeial standards, diphenhydramine is monographed in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). These monographs provide standardized specifications for the drug's quality, ensuring consistency and safety across different markets.

4India Regulatory Classification

In India, diphenhydramine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. This classification mandates that diphenhydramine can only be sold with a valid prescription from a registered medical practitioner.

The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of essential medicines in India. As of the latest available data, diphenhydramine is not listed under the Drugs (Prices Control) Order (DPCO), suggesting that it is not subject to price control regulations. However, manufacturers should regularly consult the NPPA for any updates to pricing policies.

For exporting diphenhydramine, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT). This certificate ensures that the export complies with national regulations and does not adversely affect domestic availability.

5Patent & Exclusivity Status

Diphenhydramine has been available for several decades, and its primary patents have long expired. This has led to a robust generic market with significant competition among manufacturers. The absence of active patents facilitates the production and export of diphenhydramine by multiple Indian pharmaceutical companies, contributing to the global supply of this essential medicine.

6Recent Industry Developments

In September 2020, the FDA issued a Drug Safety Communication warning about serious problems associated with high doses of diphenhydramine. This alert was prompted by reports of teenagers participating in the "Benadryl Challenge" on social media, leading to hospitalizations and deaths. Manufacturers and exporters should be aware of such safety communications, as they can influence regulatory scrutiny and market demand.

As of March 2026, there have been no significant policy changes or new approvals related to diphenhydramine reported by major regulatory agencies such as the FDA, EMA, or India's CDSCO. However, the pharmaceutical industry is dynamic, and stakeholders should continuously monitor regulatory updates to ensure compliance and capitalize on market opportunities.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Diphenhydramine

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and intermediates, with China supplying approximately 70–80% of global KSMs and 60–70% of intermediates. This dependency exposes Indian manufacturers to supply chain vulnerabilities, particularly when Chinese production faces disruptions due to environmental regulations or geopolitical tensions.

For instance, in July 2018, environmental crackdowns in China led to the shutdown of several chemical plants, causing a ripple effect on global pharmaceutical supply chains. Indian API manufacturers experienced increased costs and supply shortages, highlighting the risks of over-reliance on a single source for critical raw materials.

2Supplier Concentration & Single-Source Risk

The export market for Diphenhydramine from India is notably concentrated, with the top five exporters—ELYSIUM PHARMACEUTICALS LTD, MICRO LABS LIMITED, REAL DRUGS PRIVATE LIMITED, GRANULES INDIA LIMITED, and TRUECARE BIOMEDIX—accounting for 59.9% of total exports. ELYSIUM PHARMACEUTICALS LTD alone holds a 19.0% share, indicating a significant reliance on a limited number of suppliers.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2020, aiming to boost domestic API manufacturing and reduce dependence on imports. By 2025, the scheme had attracted investments exceeding ₹4,570 crore, fostering local production capabilities and enhancing supply chain resilience. (pharmanow.live)

Access Complete Diphenhydramine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,430 transactions across 82 markets.

Request Demo View Pricing

Frequently Asked Questions — Diphenhydramine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top diphenhydramine exporters from India?

The leading diphenhydramine exporters from India are ELYSIUM PHARMACEUTICALS LTD, MICRO LABS LIMITED, REAL DRUGS PRIVATE LIMITED, and 11 others. ELYSIUM PHARMACEUTICALS LTD leads with 19.0% market share ($6.1M). The top 5 suppliers together control 59.9% of total export value.

What is the total export value of diphenhydramine from India?

The total export value of diphenhydramine from India is $32.0M, recorded across 1,430 shipments from 178 active exporters to 82 countries. The average shipment value is $22.3K.

Which countries import diphenhydramine from India?

India exports diphenhydramine to 82 countries. The top importing countries are UNITED STATES (63.9%), GHANA (16.6%), ETHIOPIA (2.7%), CHAD (2.2%), BENIN (2.1%), which together account for 87.5% of total export value.

What is the HS code for diphenhydramine exports from India?

The primary HS code for diphenhydramine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Diphenhydramine

Diphenhydramine

How India Exports Diphenhydramine to the World

Top Diphenhydramine Exporters from India

Top Countries Importing Diphenhydramine from India

Who Supplies Diphenhydramine to India?

Quick Facts

Related Antihistamines & Allergy

Related Analysis

Need Details?

Regulatory Landscape — Diphenhydramine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Diphenhydramine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Diphenhydramine Trade Intelligence

Frequently Asked Questions — Diphenhydramine Exports from India

Who are the top diphenhydramine exporters from India?

What is the total export value of diphenhydramine from India?

Which countries import diphenhydramine from India?

What is the HS code for diphenhydramine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of diphenhydramine exports from India?

Which ports handle diphenhydramine exports from India?

Why is India a leading exporter of diphenhydramine?

What certifications do Indian diphenhydramine exporters need?

How many buyers import diphenhydramine from India?

What is the market share of the top diphenhydramine exporter from India?

Analysis Methodology